(Total Views: 484)
Posted On: 08/16/2025 10:05:07 AM
Post# of 155902
For Alzheimer's patients, there's a new possible way to deliver drugs across the blood-brain barrier, here's the NY Times summary:
https://enews.wvu.edu/files/d/17caa526-41dc-4...-times.pdf
My question is - since Leronlimab is considered a "large" molecule antibody, how does it cross the blood-brain barrier when only 1% of other drugs (like aducanumab) get through?
https://enews.wvu.edu/files/d/17caa526-41dc-4...-times.pdf
My question is - since Leronlimab is considered a "large" molecule antibody, how does it cross the blood-brain barrier when only 1% of other drugs (like aducanumab) get through?
(8)
(0)
